Dose Dense Carboplatin, Taxotere and Herceptin As Primary Systemic Therapy in Breast Cancer
NCT00232479
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
trastuzumab, docetaxel and carboplatin in dose dense regimen
Sponsor
University of Miami
Collaborators
[object Object]